Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 636-00-0, Oxidopamine hydrobromide, Oxidopamine (hydrobromide), 6-hydroxydopamine hbr, 6-ohda, 2,4,5-trihydroxyphenethylamine hydrobromide
Molecular Formula
C8H12BrNO3
Molecular Weight
250.09  g/mol
InChI Key
MLACDGUOKDOLGC-UHFFFAOYSA-N
FDA UNII
TWC1D4W0WB

A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-(2-aminoethyl)benzene-1,2,4-triol;hydrobromide
2.1.2 InChI
InChI=1S/C8H11NO3.BrH/c9-2-1-5-3-7(11)8(12)4-6(5)10;/h3-4,10-12H,1-2,9H2;1H
2.1.3 InChI Key
MLACDGUOKDOLGC-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=C(C(=CC(=C1O)O)O)CCN.Br
2.2 Other Identifiers
2.2.1 UNII
TWC1D4W0WB
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 6 Hydroxydopamine

2. 6-hydroxydopamine

3. 6-ohda

4. Hydrobromide, Oxidopamine

5. Hydrochloride, Oxidopamine

6. Oxidopamine

7. Oxidopamine Hydrobromide

8. Oxidopamine Hydrochloride

2.3.2 Depositor-Supplied Synonyms

1. 636-00-0

2. Oxidopamine Hydrobromide

3. Oxidopamine (hydrobromide)

4. 6-hydroxydopamine Hbr

5. 6-ohda

6. 2,4,5-trihydroxyphenethylamine Hydrobromide

7. 5-(2-aminoethyl)benzene-1,2,4-triol Hydrobromide

8. 6-ohda Hbr

9. Mfcd00012894

10. Twc1d4w0wb

11. 2-(2,4,5-trihydroxyphenyl)ethylamine Hydrobromide

12. 1,2,4-benzenetriol, 5-(2-aminoethyl)-, Hydrobromide

13. 6-hydroxydopamine Hydrobromide;6-ohda Hydrobromide

14. Nsc-238469

15. 636-00-0 (hbr)

16. 6-hydroxydopamine Hydrogen Bromide

17. Mls002207128

18. 2,5-dihydroxytyramine Hydrobromide

19. Smr001306725

20. Einecs 211-247-0

21. Unii-twc1d4w0wb

22. Nsc 238469

23. 5-(2-aminoethyl)-4-hydroxypyrocatechol Hydrobromide

24. 5-(2-aminoethyl)benzene-1,2,4-triol;hydrobromide

25. 6-ohda Hydrobromide

26. 6-hydroxydopamine.hydrobromide

27. Schembl738049

28. 4-chlorobenzenecarbaldehydeoxime

29. Chembl1718398

30. Hy-b1081a

31. Dtxsid30212972

32. Wln: Z2r Bq Dq Eq &eh

33. Bcp25700

34. Ex-a4152

35. 6-hydroxydopamine Hydrobromide, 95%

36. Nsc238469

37. S5324

38. Akos015916618

39. Ccg-266959

40. Cs-5966

41. As-40064

42. Sy102034

43. Db-054509

44. B7099

45. Ft-0632700

46. M01851

47. 6-ohda Hydrobromide6-hydroxydopamine Hydrobromide

48. A935047

49. 1,4-benzenetriol, 5-(2-aminoethyl)-, Hydrobromide

50. 5-(2-aminoethyl)-1,2,4-benzenetriol Hydrobromide

51. 6-hydroxydopamine Hydrobromide, >=90% (hplc), Solid

52. Q27290460

53. 1,2,4-benzenetriol, 5-(2-aminoethyl)-, Hydrobromide (1:1)

54. 6-ohda Hbr; 6 Ohda Hbr;oxidopamine Hydrobromide; 6-hydroxydopamine Hbr

55. 6-hydroxydopamine Hydrobromide, Contains Ascorbic Acid As Stabilizer, >=98% (hplc)

2.4 Create Date
2005-07-19
3 Chemical and Physical Properties
Molecular Weight 250.09 g/mol
Molecular Formula C8H12BrNO3
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Exact Mass249.00006 g/mol
Monoisotopic Mass249.00006 g/mol
Topological Polar Surface Area86.7 Ų
Heavy Atom Count13
Formal Charge0
Complexity142
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Sympatholytics

Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)


Adrenergic Agents

Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)